ArticleMolecular therapy : the journal of the American Society of Gene Therapy2024
Novel engineered recombinant ACE2 reduces SARS-CoV-2-induced COVID-19 without cardiotoxic side effects.
Federico Ávila-MorenoPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.